Search for a reference number
We would very much appreciate your help with our national survey of Violence against staff policy by answering these two questions.
1: Does your organisation provide support to staff who have experienced violence from service users or their carers?
2: Does your organisation have a policy in place, on how to support staff that have experienced violence from service users or their carers?
Thanking you
We’re looking to conduct FOI requests with NHS trusts regarding prescriptions issued for sleep medications in the UK. For example, how many prescriptions were issued for sleep medications (e.g. Zopiclone, melatonin) in the last 5 years
• Total number of sleep disorders recorded in the last five years (broken down by year) and split by age range – I have attached a spreadsheet with the full list.
• The total number of drug prescriptions issued for the following sleep disorders in the past five years (broken down by year and by drug type e.g. Melatonin, Benzodiazepines, Z-drugs)
• The total number of patients referred to non-drug treatments, such as CBT-I
Please provide the following information-
1. The trust’s total planned CIP/efficiency savings for 2025-26 (£)
2. What a) % proportion and b) value of CIPs are not identified, at the date of this request being received?
3. The CIP/efficiency plan for 2025-26 as a % of operating expenses (as reported to NHS England).
4. Total planned ‘recurrent’ and ‘non recurrent’ CIP/efficiency savings for 2025-2026
5. Total CIPs/efficiencies for 2025-26 broken down to ‘pay’, ‘non-pay’ and ‘income’, in £
Please could you provide the following information: General Information
1. The total number of radiology scans performed at NHS hospitals in the last 12 months, broken down by modality (CT, MRI, and nuclear medicine scans).
2. A detailed breakdown of the scans performed by body part for each of the above modalities (For example CT head, MRI Spine, bone scan etc) at each trust.
3. The total number of outsourced scans for reporting purposes, categorized by modality (CT, MRI, and nuclear medicine) for each hospital / trust. Outsourcing and Teleradiology
4. Whether any radiology scans are outsourced to external providers by the hospitals.
5. The percentage of scans outsourced for each modality, if applicable at each hospital.
6. The names of the external providers contracted for outsourced radiology reporting to each NSH hospital.
7. The cost per scan for outsourced services, broken down by modality and body part. Financial Information
8. The total expenditure on outsourced radiology reporting services in the last financial year per trust.
9. Whether there are fixed pricing agreements between teleradiology providers and the hospitals, and if so, the details of these agreements to include start and finish dates and the cost in pounds. Contracts and Agreements
10. Any active contracts the hospitals have with teleradiology companies, including: a. The names of the contracted providers. b. The start and end dates of the contracts. c. The performance or quality metrics outlined in the contracts. Backlogs and Reporting Times
11. The current backlog for radiology scan reporting, broken down by modality and body part at each NHS trust.
12. The average reporting time for in-house radiology scans, categorized by modality.
13. The average reporting time for outsourced scans.
14. Whether specific modalities or body parts have more significant backlogs. Additional Details
15. Any delays in reporting radiology scans over the last 12 months and the primary causes of such delays.
16. Whether the hospital has plans to reduce reliance on outsourcing for radiology reporting, and if so, the details of these strategies.
I am writing under the Freedom of Information Act 2000 to request the following information;
1) Has your organisation been notified of any data breach or security incident in the last 3 years involving systems built upon or integrated with Salesforce?
2) Has your organisation experienced, or been informed of, any incidents relating to procurement or contract management systems that operate using Salesforce, namely the Atamis e-Procurement suite of software?
Please provide details of;
• The date the incident occurred
• The nature of the compromised data (such as commercial, personal, financial)
• If the breach was reported to the Information Commissioner’s Office
• Any remedial action taken by your organisation
3) Further to this, has your organisation undertaken any risk assessments in relation to the use of systems integrated with Salesforce. If so, please provide a summary of the findings.
Dear Sir/Madam,
I am writing under the Freedom of Information Act to make a request for information on the use of electroconvulsive therapy (ECT).
The information being requested is as follows:
1. Please provide the number of ECT treatments given to patients in the year 2025 to date (with the date range this applies to)
2. Please provide the number of patients having received ECT treatment in the year 2025 to date (with the date range this applies to)
I look forward to hearing from you in due course.
I am writing to request information under the FOI Act about your CAMHS services/neurodevelopmental assessment services for Children and Young People. If you cannot provide this information, please tell me where I can find it.
Please tell me:
1. The number of young people on your waiting list for a first appointment (assessment) as of the date of this email or nearest available.
2: The average length of time young people are currently waiting between referral and first appointment (assessment)
3: The average length of time young people are currently waiting between initial referral and first therapeutic intervention.
4: How many young people assessed were not offered follow up treatment at Camhs in the year 2024-25, as a number and a proportion of the total of young people assessed?
5: The longest time any young person has been on your current waiting list (as of the date of the receipt of this email or nearest)
6: The average wait between referral and assessment for neurodevelopmental/neurodiverse conditions on the date of this request or nearest available data.
7: The number of young people on the waiting list for neurodevelopmental/neurodiverse assessments on the date of this request or nearest available data.
Good afternoon,
After extensive research, we have been unable to find the following data, and I would now like to request it from you.
Please can I request the number of CT scans referred from primary care for SCITID 12295008 Bronchiectasis, and if you have open access to CT scans from primary care.
Best wishes,
Dear NHS Trust officers,
I’m writing to request some information under the Freedom of Information Act.
For each month in the past 2 years (Aug 2023 – Aug 2025), please let me know:
1) the Number of people’s bodies that were moved between hospitals’ mortuaries
2) the Median and Maximum number of days for a body to be released from a hospital mortuary to a funeral director
Please provide such data electronically, ideally as a spreadsheet.
I am writing to request the following information under the Freedom of Information Act 2000 in relation to permanent medical recruitment at your Trust:
1. A list of all permanent medical vacancies (e.g., Consultant or Specialty Doctor level) that have been advertised but remain unfilled, including the relevant specialties, over the past 12 months.
2. The number of permanent medical appointments made by the Trust during the same 12-month period.
3. The name, job title, and contact email address of the person who oversees and is responsible for all permanent medical recruitment across the Trust.
This request is made for research and planning purposes only and is not promotional in nature.
Please do not hesitate to contact me if any part of the request requires clarification.
I am writing under the Freedom of Information Act 2000 to request the following information:
A list of all technology-related contracts currently held by the Trust with companies headquartered in the United States, where the contract value exceeds £25,000 per annum.
For each relevant contract, please provide:
• Name of the company
• Description of the product or service.
Dear Gloucestershire Health and Care NHS Trust,
I am writing to request the following information under the Freedom of Information Act 2000:
1. The year of purchase of every LINAC machine in operation at your trust?
Kind Regards,
I am requesting a Mental Health Service Clinical Policy specifying the Clinical Procedure in respect of minimising the dangers of hyperprolactinemia balancing the need for anti psychotic stability with managing elevated prolactin levels and long term health risks.
Under the Freedom of Information Act 2000, I request information about medical call-outs or hospital admissions related to football matches at Premier League stadiums in your area.
Time Period: 2023/24 season and any available data from the 2024/25 season
Stadium-Specific: If possible
1. Number of ambulance call-outs or medical assistance requests from stadiums on matchdays.
2. Number of hospital admissions linked to injuries or incidents at the stadium (if available).
3. If possible, please indicate:
– The type of incident (e.g., collapse, injury, intoxication)
A breakdown by stadium and match date would be appreciated.
If possible, please provide the information in an Excel (.xls or .xlsx) or CSV format.
If parts of this request are not available, please provide the data that you do hold and if you have any other relevant information to premier league football games then please can you also share.
Please let me know the patient group directive or other means by which paramedics are allowed to dispense dexamethasone without medical / doctor input at community hospitals, particularly Cinderford Community Hospital. Thank you
To whom it may concern, I am writing to you under the Freedom of Information Act 2000 on behalf of Myeloma UK to request the following information: 1. Is your health trust currently treating myeloma patients 2. Please list the hospitals in your board/trust that are currently treating myeloma patients. 3. Please list how many myeloma patients are being treated by your board/trust. Please break this down by hospital. 4. Is your health trust currently treating myeloma patients with elranatamab or teclistamab. Please break this down by hospital. 5. Please list how many people have been given a) elranatamab or b) teclistamab since approval by the National Institute of Health and Care Excellence in 2024 (TA1023 and TA1015. If possible, please break this down by hospital. 6. Do you have a service level agreement or referral system in place with any other health trusts to deliver a) elranatamab or b) teclistamab to patients. If the answer this question is yes, which health boards / trusts do you have an agreement in place with. If you have any queries, please don’t hesitate to contact me via e-mail. Thank you for your time and I look forward to your response.
To whom it may concern, I am writing to request information under the Freedom of Information Act 2000 regarding the cyber security of your NHS Trust, specifically relating to incidents and the current measures in place to mitigate such threats. 1. Ransomware incidents (FY2022–FY2025) Please confirm whether any digital systems within hospitals managed by your NHS Trust were affected by ransomware attacks during the financial years 2022–2023 through to 2024–2025 (inclusive). If yes: How many separate ransomware incidents occurred within this period? For each incident, please provide: The date or month of occurrence A brief description of the nature of the attack (e.g. type of ransomware, point of system entry, services impacted) 2. Data breaches following cyber incidents (FY2022–FY2025) Were any data breaches reported as a result of ransomware or other cyber incidents during this period? If yes, please provide for each breach: The type(s) of data affected (e.g. patient records, staff information) The specific impacts of each breach, categorised as follows (where applicable): Loss of patient data Loss of staff data Disruption to patient services (please specify which services, if known) Disruption to operational processes Financial impact (e.g. cost of recovery, penalties, compensation, etc.) Other impacts – please specify 3. Current cyber security measures (as of date of request) Please list all cyber security measures and protocols currently in place across the Trust. These may include, but are not limited to: Cyber insurance (including provider and coverage if available) Internal and external firewall systems Use of multi-factor authentication (MFA) for user accounts Access control systems for sensitive data and critical systems Anti-virus and anti-malware protection Cyber security training or awareness programmes for employees Regular penetration testing or security audits (please specify frequency) Existence and status of an incident response plan (e.g. last updated date) I look forward to your reply.
Please can you provide me with the following information:
• Do you use a master or neutral vendor for your supply of Medical Staff (Doctors – all grades)?
• If yes, please supply the name of the master or neutral vendor
• When does the contract expire?
• What is the name of the e-rostering platform that you use to support with medical staff rosters e.g. RL Datix, Rotageek etc
• When does the contract expire?
This is an information request relating to Pride month 2025
Please include the following information:
Whether any events have been organised for Pride month. If so please provide the date, start and end time, and title/topic of the event
Whether any LGBT themed merchandise has been purchased for Pride month. i.e. since the beginning of the 2025/26 financial year. If so please provide me with information on what has been purchased and the cost
Whether the organisation have sponsored any Pride events. If so which events and please provide details of the nature of the sponsorship (particularly the financial value)
I am writing to make a formal request under the Freedom of Information Act 2000 for information regarding your organisation’s procurement activities and current contracts.
Information Requested:
1. Current Procurement Opportunities
• Details of any ongoing procurement exercises or tenders currently open or planned to commence within the next 12 months
• Estimated contract values and duration
• Key procurement contact details
2. Existing Contract Information
• List of major contracts (over £50,000 annual value) due for renewal or review in the next 24 months
• Contract end dates and review periods
• Primary contract categories
Scope: Please provide information covering the period from [current date] to [24 months forward];
I am writing to request information under the Freedom of Information Act 2000. Please provide the following information for your Trust for the period from 1st April 2025 to the date of this request:
1. Agency Spend Breakdown (April 2025 – Present)
For each month, please provide the total amount spent on:
a. Clinical Nurses:
• Via NHS-approved framework agencies
• Via off-framework agencies
Please separate the above by Agenda for Change (AfC) banding levels (e.g. Band 2, Band 5, Band 6, etc.).
b. Medical Doctors:
• Via NHS-approved framework agencies
• Via off-framework agencies
Please break down the above by grade (e.g. FY1, SHO, Registrar, Consultant) and specialty (e.g. A&E, General Medicine, Psychiatry).
2. Agency Details
Please provide the names of the agencies used in each category above (framework and off-framework) for nurses and doctors.
3. Activity Data (if available)
If available and within the appropriate cost/time limits, please also include the number of shifts or hours filled for each staff group, broken down as above.
Freedom of Information Request – Ref: FOI 169-2025 Thank you for your recent Freedom of...
I keen to understand how much use the Acute Trust specialists are able to make of the Outpatient clinic facilities in Gloucestershire’s Community Hospitals. I am particularly interested in to know what Acute Trust services are provided at Moreton Community Hospital, although the question is also relevant to all of Gloucestershire’s Community Hospitals.
I believe that prior to the Pandemic good use of Moreton’s clinic space by Acute Trust Consultants etc was made, but that now clinics are few and far between – physio, orthoptists, hearing aid support. Your website suggests that clinics are held in response to demand. What constitutes “demand”?
Given the Secretary of State’s wish to move more specialist provision into the community, it would be helpful to know to what extent that already happens in our Community Hospitals, and what are the issues that prevent greater use. I guess that cost is a major block to greater use – but who bears what cost (GHC? GHT? ICB?)
As background, I am a retired GP and am currently a Public Governor at Gloucestershire Hospitals Trust. This issue has recently been raised with me by PPG members from North Cotswolds GP Practices. Residents in that area have long journey times to and from GRH or CGH, and are increasingly frustrated that OP clinics appear not to be held in the excellent facility at Moreton and elsewhere. I have family living in North Cotswolds too and understand their frustrations.
Would it be possible to provide me with a timetable of current use of Moreton clinic space, or would that need to go through FOI channels?
Good morning,
Under the FOI act please can you confirm the following:
Please confirm if you operate a vendor management system for agency staff such as an MSP/neutral vendor/master vendor etc.
If so, please can you name the below:
-Company name
-Contract start and end date
-Framework utilised
-Healthcare specialty used for, EG Doctors/Nursing/AHP/HSS/NMNC
-Do you utilise a direct engagement model and the name of the model, eg Tempre/Own DE model etc
Please confirm if you operate a vendor management system for bank staff.
If so, please can you name the below:
-Company name
-Contract start and end date
-Framework utilised
-Healthcare specialty used for, EG Doctors/Nursing/AHP/HSS/NMNC
Thanks
I am kindly requesting the information below, and If any element risks exceeding the FOI cost limit (£450), or contains disclosable personal data, please let me know which parts could be modified or removed to bring the request within the limit. I am happy to accept redacted or summarised information where necessary.
For the years 2017-2022, please provide:
i) Annual trust-level totals:
1. Referrals to the NHS Counter Fraud Authority (count)
2. Number of suspected fraud incidents
3. Number of proven fraud incidents (disciplinary or criminal)
4. £ value lost (total)
5. £ value recovered (total)
Or:
i) For each period (monthly is preferred; quarterly is acceptable), please provide:
1. Cases opened (count)
2. Cases closed (count)
3. Closure outcomes – counts by category:
[No fraud/irregularity, Management/disciplinary action, Civil recovery pursued Referred for criminal investigation/prosecution, Criminal sanction obtained] 4. Referrals to the NHS Counter Fraud Authority (count) 5. Estimated financial loss/exposure recognised in the period (£) 5. £ value recovered (total)
ii) Case-level details (each incident):
1. Date discovered (DD/MM/YY)
2. Discovery method (audit, whistle-blower, analytics, other) 3. Fraud type (procurement, payroll, patient, drug, cyber, other) 4. £ value lost / exposure 5. £ recovered to date
iii) Payment practice signal
Better Payment Practice Code: percentage of invoices paid later than 30 days, by month.
I would be grateful if the information was supplied in CSV format with the organisational code and financial year.
This request specifically concerns a child aged 14 who has been referred for neurodevelopmental assessment.
I would be grateful if you could confirm:
1. The current average waiting time for children referred and accepted for neurodiversity testing.
2. The referral date (month and year) of the most recent cohort currently being invited to attend their initial assessment.
3. Whether the Trust maintains separate waiting lists or pathways for different age groups (e.g. under-16s vs adults).
4. Any projected changes to waiting times or service capacity for paediatric neurodiversity assessments in the next 6–12 months.
If available, please include any internal guidance, reports, or service planning documents used to manage or forecast waiting list progression.
I would prefer to receive the information electronically. If any part of this request is unclear or would incur a cost, please let me know so I can refine it.
Please provide the following information, broken down by month, between January 2020 and July 2025 inclusive. If this is not possible, please instead provide it broken down by calendar year, 2020 to 2025 inclusive.
1. The number of times a patient was admitted where exposure to air pollution (International Classification of Diseases, tenth revision (ICD-10) code Z581)* was recorded as a contributing factor to the admission.
(* I understand this is the code used by NHS trusts to log exposure to air pollution, but if your trust uses a different code or some other system, please still provide the relevant data)
1a. If possible, please tell me what the primary diagnosis was for each of these admissions.
(For clarity, I want to know total numbers admitted with each primary diagnosis — for example, if 45 people were admitted with a primary diagnosis of asthma where exposure to air pollution was identified as a contributing factor.)
2. Please tell me how many of the patients in question 1 subsequently died in hospital.
If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
If you can identify any ways that my request could be refined I would be grateful for any further advice and assistance.
If you are able to supply some of this information more quickly than other items, please supply each item when you can rather than delay everything until it is all available.
Please treat this as a freedom of information request.
Please provide:
1. Total planned capital spend in 2025-26
2. Planned research spend in 2025-26.
I’d like to make the following request under the freedom of information act.
Could you tell me, for 2019-2025
a) how many patients were transferred out-of-area
b) the furthest distance a patient was transferred
c) the longest period a patient was placed in an out-of-area trust
Freedom of Information Request
1. Do you have a policy (or policies) which outlines the responsibilities of health and care professionals and the Trust towards a patient who has an Advance Decision to Refuse Treatment (ADRT) or Lasting Power of Attorney (LPA) for Health and Welfare?
This document might include:
– how an ADRT/LPA should be used in decisions about a person’s treatment,
– what to do if there are doubts about the validity and/or applicability of the document,
– how to involve Health and Welfare Attorneys when making treatment decisions
– how or when decisions will be referred to the Court of Protection
If yes, please share a copy with us in any available format.
2. In the event that a patient or family member, or someone using the Trust’s services has a concern about the implementation of an Advance Decision to Refuse Treatment (ADRT) or a Lasting Power of Attorney (LPA) for Health and Welfare, does the Trust/Health Board have a documented process or course of action that would be provided to the person to allow them to resolve their concerns?
If yes, please share a copy with us.
If this information is covered within a policy you have included in the response above, please leave blank.
3. Do you have a named individual who is responsible for overseeing the Trust’s compliance with the Mental Capacity Act 2005?
If yes, please share their contact details.
Dear Gloucestershire Health and Care FOI Team,
Under the Freedom of Information Act 2000, I would like to request details of all vehicles currently used or operated by Gloucestershire Health and Care, whether owned, leased, or otherwise provided for use by the Trust. For each vehicle, please provide the following information: Make and model Body colour Date of first registration with the DVLA Date of the next MOT (where applicable – I am aware that vehicles under three years old are exempt from MOT testing) I would also be grateful if you could confirm whether the Trust itself holds the V5C registration documents for these vehicles, or whether these are retained by a leasing company or another third party.
The information requested relates only to basic vehicle details and statutory roadworthiness requirements.
It does not include registration marks or any personal data, and should therefore be straightforward to disclose.
If possible, I would appreciate the information in a spreadsheet format such as CSV or Excel. Thank you for your assistance.
Dear colleagues,
We are undertaking a survey regarding the management pathway of elderly patients (>65 years old) presenting with trauma in the Emergency Department.
I am emailing you to a make freedom of information request with regard to trauma protocols for silver trauma patients. We would like to know the following information if available:
. Does your hospital have a guideline for silver trauma patients (>65 years old) attending ED?
. What are the ED’s indications for initiating a silver trauma call and requesting a trauma CT for elderly patients at your hospital?
· Which specialties are called for silver trauma in ED? Does it include General surgery, Orthopaedics, Anaesthetics and Medicine of the elderly?
· Does your hospital have a guideline for assessing delirium in silver trauma patients (>65 years old)?
· Do all the silver trauma patients get reviewed by medicine of the elderly on the ward if admitted? · Do you have a guideline for assessment of the silver trauma patients on the ward by medicine of the elderly?
· Can you please attach your hospital’s guidelines for silver trauma patients in your reply?
Thank you for your help! Looking forward to your response.
Please do not include any patient confidential information in your response.
Dear FOI Officer, I am writing to request information, under the Freedom of Information Act 2000, regarding carbon monoxide (CO) cases in relation to research for Project SHOUT.
Could you please provide the following information, from the Gloucestershire Health and Care NHS Foundation Trust, for the periods: 1st August 2018 to 31st July 2019:
• The total number of carbon monoxide (CO) cases that attended A&E
1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over
• The total number of carbon monoxide (CO) cases that were treated at A&E
1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over 1st August 2019 to 31st July 2020:
• The total number of carbon monoxide (CO) cases that attended A&E
1. Of the total figure, how many were aged 0-18 years old 2.
Of the total figure, how many were aged 60 years old and over
• The total number of carbon monoxide (CO) cases that were treated at A&E
1. Of the total figure, how many were aged 0-18 years old
2. Of the total figure, how many were aged 60 years old and over 1st August 2020 to 31st July 2021:
• The total number of carbon monoxide (CO) cases that attended A&E
1. Of the total figure, how many were aged 0-18 years old
2. Of the total figure, how many were aged 60 years old and over
• The total number of carbon monoxide (CO) cases that were treated at A&E
1. Of the total figure, how many were aged 0-18 years old
2. Of the total figure, how many were aged 60 years old and over 1st August 2021 to 31st July 2022:
• The total number of carbon monoxide (CO) cases that attended A&E
1. Of the total figure, how many were aged 0-18 years old
2. Of the total figure, how many were aged 60 years old and over
• The total number of carbon monoxide (CO) cases that were treated at A&E
1. Of the total figure, how many were aged 0-18 years old
2. Of the total figure, how many were aged 60 years old and over 1st August 2022 to 31st July 2023:
• The total number of carbon monoxide (CO) cases that attended A&E
1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over
• The total number of carbon monoxide (CO) cases that were treated at A&E
1. Of the total figure, how many were aged 0-18 years old
2. Of the total figure, how many were aged 60 years old and over 1st August 2023 to 31st July 2024:
• The total number of carbon monoxide (CO) cases that attended A&E
1. Of the total figure, how many were aged 0-18 years old
2. Of the total figure, how many were aged 60 years old and over
• The total number of carbon monoxide (CO) cases that were treated at A&E
1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over 1st August 2024 to 31st July 2025:
• The total number of carbon monoxide (CO) cases that attended A&E
1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over
• The total number of carbon monoxide (CO) cases that were treated at A&E
1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over If possible.
I would be grateful to receive this information in an Excel spreadsheet format.
This is an information request relating to nhs translators
Please include the following information for the following financial years 2022/23, 2023/24 and 2024/25:
• Trust’s overall spending on Translation and Interpreting Services
• Total translators employed by the Trust
• The hourly pay for in-house interpreters
• What languages do they cover
• Total number of in-person/face to face interpreting sessions booked (break down by language and clinical area)
• How many appointments or procedures have had to be rescheduled/cancelled due to interpreter
If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
Under the Freedom of Information Act 2000 I would like to request the following information.
This request relates to NHSE’s July 2025 time-series elective care waiting list release from September 2021-June 2025 which disaggregated data by age and sex and partially disaggregated by ethnicity and Indexes of Multiple Deprivation (IMD). Please provide the requested information in an Excel spreadsheet.
1. Share the paediatric elective care waiting list data (under 18) disaggregated by ethnicity and IMD for the time-series September 2021-June 2025, displayed as total numbers waiting month by month. Please indicate if this data has not been collected.
2. Share paediatric community service waiting list data (under 18) disaggregated by ethnicity and IMD for the time-series September 2021– June 2025, displayed as total numbers waiting month by month. If this data has not been collected, please provide the total waiting list for paediatric community care between September 2021-June 2025 by month.
If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
If you have any queries, please don’t hesitate to contact me via email and I will be happy to clarify. Thank you for your time and I look forward to your response.
Hi. Thank you for responding to the FOI below. I have a few follow up questions.
1. How many patients have had TMS funded by GHC in the last 24 months.
2. Could you give an estimate on total expenditure on TMS in last 24 months.
3. What providers (NHS or private) have delivered TMS funded by GHC.
Hello, earlier in the year I requested the trust abortion policy. I am looking through this and it states to read with the ultrasound policy- could I please request this?
I am submitting this request under the Freedom of Information Act 2000.
Please provide the following information:
1. Access to Testing Clinical Information Systems
o What is the approval process by which an external organisation may apply or request to connect with the trust’s test clinical systems of record. (e.g. EMR, EHR, PACS)
o Which internal teams, roles, or committees are responsible for approving such a connection?
o What steps are involved in obtaining the necessary permissions or agreements to establish such a connection?
o What is the entry point for this process? e.g. email address or webform.
2. Access to Production Clinical Information Systems
o What is the approval process by which an external organisation may apply or request to connect with the trust’s production clinical systems of record. (e.g. EMR, EHR, PACS)
o Which internal teams, roles, or committees are responsible for approving such a connection?
o What steps are involved in obtaining the necessary permissions or agreements to establish such a connection?
o What is the entry point for this process? e.g. email address or webform.
At this point we’re not asking for information regarding the technical specifics of the trust’s internal systems. We are only requesting information on the trust’s approval and decision making processes.
I am writing to submit a request for information under the Freedom of Information Act 2000.
I would be grateful if you could provide information regarding your hospitals clinical practice on the timing of methotrexate (MTX) level monitoring in patients receiving high-dose methotrexate (HDMTX) therapy. Specifically, I am seeking the following:
Adult Patients
1. For adult patients with acute lymphoblastic leukaemia (ALL) receiving HDMTX, at what time point does your centre take the first MTX level?
2. For adult patients with osteosarcoma receiving HDMTX, at what time point does your centre take the first MTX level?
3. For adult patients with non-Hodgkin’s lymphoma receiving HDMTX, at what time point does your centre take the first MTX level?
Paediatric Patients
1. For paediatric patients with acute lymphoblastic leukaemia (ALL) receiving HDMTX, at what time point does your centre take the first MTX level?
2. For paediatric patients with osteosarcoma receiving HDMTX, at what time point does your centre take the first MTX level?
3. For paediatric patients with non-Hodgkin’s lymphoma receiving HDMTX, at what time point does your centre take the first MTX level?
Please note that I am not requesting any patient-specific data. This request relates solely to your clinical practice guidelines or standard protocols.
I am writing to request information under the freedom of information act on your organisations use of Job Planning. Please can you fill out the questions for each staffing group listed in the table below-
Consultants SAS Doctors Allied Health Professionals (AHPs)
1. Does your organisation use job planning software?
2. If yes, please can you specify the name of the job planning supplier?
3. If no, could you please specify how you carry out job planning?- for example paper based, Excel, Microsoft word, Other- please state
4. What is the contract start date for your job planning supplier?
5. What is the contract end date for your job planning supplier?
6. What was the annual cost of your job planning supplier for the financial year 24/25 (April 2024 – March 2025)?
7. Is job planning in your organisation demand led?
8. If yes, what frequency is it reviewed? (Monthly, Quarterly, Annually)
9. For each staffing group what percentage of staff is job planning rolled out to?
10. What other third-party systems does your Job planning system integrate with?
Please do not hesitate to contact me if you have any questions.
Dear Gloucestershire Health and Care NHS Foundation Trust,
The information that we require, under the Freedom of Information Act, is as follows:
1) Do you use a Citizen Engagement platform?
2) If so, what tools do you use?
3) How much do you spend annually on a Citizen Engagement tool?
4) Which month & year does your contract with your supplier end?
A citizen engagement platform is a digital tool or system designed to facilitate communication, interaction, and participation between citizens and government or public institutions. Its goal is to make civic involvement easier, more transparent, and more effective.
These platforms can be used by governments, cities, or organisations to:
Collect feedback on policies, services, or community issues Conduct surveys and polls Enable reporting of local issues, like potholes or graffiti Share updates, news, and documents with the public Encourage participatory budgeting or co-creation of solutions
Examples include tools like Granicus (EngagementHQ), CitizenSpace, SurveyMonkey, Qualtrics or Commonplace They can play a major role in increasing transparency, accountability, and trust in public decision-making.
FOI request for the following data for Gloucestershire Health and Care NHS Foundation Trust:
1. The number of unique patients with a recorded diagnosis of Primary Immunodeficiency (PID) in Q2’25(April, May, and June 2025)
a. Of these PID patients, what is the number of PID patients treated with Immunoglobulin in Q2’25(April, May, and June 2025) If possible, segment patients by brand used e.g 5 patients on Cuvitru
b. How of these Ig treated PID patients are naïve (new starts) in Q2’25(April, May, and June 2025)?
2. The number of unique patients with a recorded diagnosis of Secondary Immunodeficiency (SID) in Q2’25(April, May, and June 2025)
a. Of these SID patients, what is the number of SID patients treated with Immunoglobulin in Q2’25(April, May, and June 2025? If possible, segment patients by brand used?
b. How of these Ig treated SID patients are naïve (new starts) in Q2’25(April, May, and June 2025)?
3. The number of unique patients with a recorded diagnosis of Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Q2’25(April, May, and June 2025)
a. Of these SID patients, what is the number of CIDP patients treated with Immunoglobulin in Q2’25(April, May, and June 2025? If possible, segment patients by brand used?
b. How of these Ig treated CIDP patients are naïve (new starts) in Q2’25(April, May, and June 2025)?
4. The number of immunoglobulin vials/volume in grams distributed to Gloucestershire Health and Care NHS Foundation Trust in each month for April, May, and June 2025, broken down by product (see below).
I would also like to request the number of patients Gloucestershire Health and Care NHS Foundation Trust by brand if available:
•Vigam
•Flebogamma DIF
•Gammaplex
•Gamunex-C
•Octagam
•Gamten
•Kiovig
•Intratect
•Privigen
•Iqymune
•Gammanorm
•Subcuvia
•Subgam
•Hizentra
•Hyqvia
•Cuvitru
•Panzyga
•Xembify
•Cutaquig
• Vyvgart (Efgartigimod)
Preferably I would like the data in .xlsx or .csv format. Alternatively a table will suffice
Thanks for your support.
Please can you tell me:
1. The number of patients who have died while on your waiting list to recieve consultant-led elective (planned) hospital treatment — and who have therefore been removed from the list due to to their death or status as being deceased — between January 1 2025 and July 31 2025?
(If your trust calls this particular waiting list something else, please use common sense and provide the waiting list data most relevant to my questions.)
1a. If possible, please tell me how many of these people who died had been waiting for longer than 18 weeks since being referred for consultant-led elective hospital treatment?
1b. If possible, please provide a seperate breakdown of the ethnicity and religion of all those who died while on this your waiting list to recieve consultant-led elective (planned) hospital treatment over this time period.
2. The number of patients who have died while on your waiting list to recieve consultant-led elective (planned) hospital treatment — and who have therefore been removed from the list due to to their death or status as being deceased — broken down into the years 2024, 2023, 2022, 2021 and 2020, please.
2a. If possible, please provide a seperate breakdown of the ethnicity and religion of those who died while on you waiting list for consultant-led elective (planned) hospital treatment in each of these years.
If you are encountering any practical difficulties with complying with this request, please contact me as soon as possible (in line with your duty under section 16 to advise and assist requesters), so that we can discuss the matter and if necessary I can modify the request.
If you are able to supply some of this information more quickly than other items, please supply each item when you can rather than delay everything until it is all available.
Please format this data clearly and provide it in a machine readable format (such as xslx).
Freedom of Information Request – Narcolepsy Services Please provide the following information regarding narcolepsy services provided or commissioned by your organisation: 1. Do you provide or commission narcolepsy services? • If yes, please provide: • The name and location of the service • The current Referral to Treatment Time (RTT) • The number of patients seen by the service during the most recent full financial year (to April 2025) • The number of patients the service is contracted to see • The key performance indicators (KPIs) or outcome measures are used to monitor the service. Additionally, how the services performed against the set KPIs (outcome measures) for the latest available period of time. • Whether the service is commissioned through a block contract (Yes/No). • If not, please specify: • The organisation or provider to which patients with suspected or confirmed narcolepsy are referred to.
I am writing to request information under the Freedom of Information Act 2000 regarding the implementation and evaluation of Family Integrated Care (FICare) within your neonatal services.
Please could you provide the following:
1. Confirmation of whether Family Integrated Care (FICare) is currently implemented in your neonatal unit(s), and if so, the date of initial implementation.
2. Copies of any internal policies, protocols, or guidance documents relating to FICare.
3. Details of any staff training programmes or materials used to support FICare delivery.
4. Details of any staff training programmes or materials used to support FICare delivery relating to older siblings.
5. Any audit reports, evaluations, or outcome data relating to the effectiveness or impact of FICare on neonatal care or family experience.
6. If FICare is not currently implemented, please indicate whether there are plans or discussions underway to introduce it.
In addition (and if relevant), please could the Trust provide information on its policies or regulations regarding parental and sibling access to babies receiving neonatal care:
1. Are both parents and siblings permitted to spend time with babies in neonatal care units?
2. Are there any time restrictions or limitations on how long parents or siblings may spend with babies in neonatal care?
3. Does the Trust have any policies to ensure that babies from multiple births (e.g. twins, triplets) receive equal parental contact time compared to singleton babies?
Dear Gloucestershire Health and Care NHS Foundation Trust, Under the Freedom of Information Act 2000, I am writing to request a vehicle fleet list operated by the Trust, whether owned or leased. I would appreciate it if you could provide the following details for each vehicle: – Chassis Make and Model – Registration Mark of each motor vehicle (VRM) – Date of acquisition – Date of disposal (if applicable) for vehicles decommissioned between 2020 and 2025 I would be grateful if this information could be provided in an accessible format such as Excel, Word, PDF, or text. If any of the requested information is exempt from disclosure, please share the details you can and explain the reasons for withholding any content. Should you need any clarification regarding this request, please feel free to contact me. Thank you for your time and assistance. I look forward to your response within the statutory timeframe.
Under the Freedom of Information Act 2000, I am requesting aggregate information regarding services provided or commissioned by your Trust in relation to peripheral neuropathic pain (PNP), with a specific focus on: – Post-surgical neuropathic pain (PSNP) – Cancer-related neuropathic pain (CRNP) – Painful diabetic peripheral neuropathy (PDPN) Please break down the information by individual service, clinic, and by hospital site. 1. Patient Numbers & Treatment Modalities (Last 12 Months) For each hospital site or service, please provide: The number of patients seen for each of the following conditions: – PSNP – CRNP (please split into surgically induced and chemotherapy-induced) – PDPN – Please also break this down by hospital department. Treatment Modalities For each hospital site or service, please indicate Yes or No as to whether the following treatment modalities are available for PNP. Where stated yes please provide patient numbers for the latest 12-month period. Gabapentin prescriptions Botulinum toxin (Botox) injections TENS (Transcutaneous Electrical Nerve Stimulation) Acupuncture (including PENS – Percutaneous Electrical Nerve Stimulation) Theatre-based nerve stimulation procedures (e.g., spinal cord stimulators or other implanted/surgical neuromodulation devices) If exact numbers are unavailable, proxy data is acceptable (e.g., the percentage of neuropathic pain patients receiving each treatment modality). 2. Service Provision Does your Trust or provider offer specific or dedicated services for PSNP, CRNP, and/or PDPN? – If yes, please list each relevant service or site (e.g., pain clinic, neurology clinic, diabetic foot clinic, community pain service) along with their addresses. For each listed site or service, please indicate: – The types of healthcare professionals routinely involved (e.g., pain specialists, neurologists, specialist nurses, physiotherapists, psychologists) – The number of staff per role (headcount or FTE if available) 3. Referral Pathways & Service Specifications Are there established care pathways, referral criteria, or service specifications for PSNP, CRNP, and/or PDPN? – If yes, please supply relevant documents or summaries. – If not, please clarify whether these conditions fall under broader chronic pain, MSK, diabetes, or oncology pathways. 4. Clinical Guidelines, Protocols, Strategic Plans Has the Trust developed or contributed to any strategic plans, business cases, or service specifications for PSNP, CRNP, or PDPN? – If so, please provide relevant documents, including any timelines and associated funding information. Are there any specific clinical guidelines, care pathways, or treatment protocols in use? For example: – NICE CG173 – NEUPSIG – Local pathways for diabetes- or oncology-related neuropathy – If yes, please provide copies or summaries of key components. 5. Funding & Budgets What was the total expenditure on neuropathic pain services in the most recent full financial year? – If no specific figure is available, please provide overall pain management funding and any known distribution (e.g., primary/community vs secondary care). – Please indicate the type of funding, e.g. tariff or block contract 6. Planned or Recent Service Changes Are there any recent, ongoing, or planned changes to: – Commissioning arrangements – Referral pathways – Service structure – Clinical treatment options for PSNP, CRNP, or PDPN? If yes, please provide details, including the relevant sites, timelines, and the rationale for these changes. 7. Data Format and Guidance Please provide all data in a machine-readable format (e.g., Excel or CSV). – If any part of the request is unclear or may exceed appropriate cost/time limits, please contact me to discuss refinement, in accordance with Section 16 of the FOI Act.
Please treat this as a freedom of information request.
Please provide:
1. Planned spend on agency staff in 2025-26
2. Planned spend on bank staff in 2025-26
Under the Freedom of Information Act I am requesting the following information from the trust:
1. The number of harm reviews carried out on lung cancer patients who faced lengthy waits for treatment between 1 January 2023 and 31 December 2024 (please do not include incomplete reviews)
2. The number of cases where harm was found in lung cancer patients and the level of harm in each: e.g, low harm, medium harm, severe harm
3. In lung cancer cases where there was severe harm, please provide a short but specific description of what the harm was: e.g. stage migration, patient moved straight to palliative care etc;
4. After how many days does the trust initiate harm reviews of lung cancer patients that have faced lengthy waits for treatments? (please state a number and do not include links to policies)
I am writing to request the following information under the Freedom of Information Act 2000 regarding your Trust’s use of Master Vendor and/or Neutral Vendor staffing arrangements:
Master Vendor Service
1. Does your Trust have a Master Vendor service in place?
2. If yes, which agency provides this service?
3. What technology platform is used to manage this service?
4. What is the end date of the current agreement/contract?
5. What cost (if any) is incurred by the Trust for this service?
6. Which staffing groups are covered under the Master Vendor service?
7. What is the average fill rate achieved under this service over the past 12 months?
Neutral Vendor Service
1. Does your Trust have a Neutral Vendor service in place?
2. If yes, which agency provides this service?
3. What technology platform is used to manage this service?
4. What is the end date of the current agreement/contract?
5. What cost (if any) is incurred by the Trust for this service?
6. Which staffing groups are covered under the Neutral Vendor service?
7. What is the average fill rate achieved under this service over the past 12 months?